Skip to main content
Clinical Trials/NCT00933218
NCT00933218
Completed
Not Applicable

Effects of Polyphenols on Changes of Inflammatory and Cardiovascular Status After a Marathon Run

Technical University of Munich1 site in 1 country250 target enrollmentJune 2009

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Inflammation
Sponsor
Technical University of Munich
Enrollment
250
Locations
1
Primary Endpoint
Inflammatory marker: Interleukin 6 and Interleukin 10
Status
Completed
Last Updated
15 years ago

Overview

Brief Summary

The purpose of the study is to determine the myocardial function and vascular adaptation after strenuous exercise in association with consumption of polyphenols. The investigators aim to investigate the effects of extreme endurance exercise on the inflammatory system. Furthermore, the role of the cardiovascular response and adaptive mechanisms of the vasculature are examined. Subclinical injuries to the myocardium and vascular wall are being investigated.

Detailed Description

Regular exercise leads to an improvement of cardiovascular risk factors in patients with coronary heart disease, atherosclerosis and metabolic disorders. Aerobic exercise has anti-inflammatory effects. In contrast, the exertional exercise of marathon running causes an acute pro-inflammatory impulse. This may lead to myocardial injury and, in case of preexisting plaques, may result in plaque rupture and acute myocardial infarction. We aim to define the critical role of inflammatory markers and cardiovascular risc factors as a predictor of an increased risk for myocardial and endothelial dysfunction in marathon runners. Diagnostic tools include measurements of microvasculature, the large vessels and echocardiography. Inflammatory markers include high sensitive c-reactive protein (CRP) and interleukins. All variations are analysed on the basis of consumption of polyphenols as they are found in in hops (Humulus lupus L.) and beer.

Registry
clinicaltrials.gov
Start Date
June 2009
End Date
November 2009
Last Updated
15 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Male

Investigators

Sponsor
Technical University of Munich

Eligibility Criteria

Inclusion Criteria

  • men aged 20-60 years

Exclusion Criteria

  • manifested heart disease
  • insulin dependent diabetes mellitus
  • multi drug therapy
  • GFR \< 60 ml/min
  • neoplasia
  • (former) alcoholism
  • known malabsorption
  • known chronic inflammatory disease

Outcomes

Primary Outcomes

Inflammatory marker: Interleukin 6 and Interleukin 10

Time Frame: pre-, post-, one & three day follow-up

Secondary Outcomes

  • E/E' ratio(pre-, post-, one & three day follow-up)
  • AV-ratio(pre-, post-, one & three day follow-up)

Study Sites (1)

Loading locations...

Similar Trials